Pain of cesarean delivery wound. Disruption of cesarean delivery wound
Conditions
Interventions
Intervention 1: Intervention group: Intravenous Midazolam 1 mg plus Ketamine (manufactured by Opterop pharmaceutical Co.) 0.5 mg/kg single dose before cesarean section. Intervention 2: Control group:
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
13 Years to 35 Years
Inclusion criteria
Inclusion criteria: Age of 18 to 35 years; Candidate for elective cesarean section; Gestational age of 36 to 40 weeks;
Exclusion criteria
Exclusion criteria: History of cardiac disease; Hypersensitivity to Ketamine; Renal or liver disease; Hypertension or hyperthyroidism; History of convulsion; Alcohol or drug abuse; Contraindication of spinal anesthesia; Psychological disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: On 2, 4, and 6 hours after cesarean section. Method of measurement: Using Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: On 2, 4, and 6 hours after cesarean section. Method of measurement: Via taking history.;Vertigo. Timepoint: On 2, 4, and 6 hours after cesarean section. Method of measurement: Via taking history.;Hypotension. Timepoint: On 2, 4, and 6 hours after cesarean section. Method of measurement: Via physical examination by sphygmometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Fasihi
Hamedan University of Medical Sciences
Outcome results
None listed